September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Nicolas Sayegh: Zeynep Irem Ozay Presented Real-World Data on Lutetium vs. Cabazitaxel in mCRPC at ASCO 2025
Jun 3, 2025, 17:21

Nicolas Sayegh: Zeynep Irem Ozay Presented Real-World Data on Lutetium vs. Cabazitaxel in mCRPC at ASCO 2025

Nicolas Sayegh, Genitourinary Oncology Research Fellow at Huntsman Cancer Institute, shared an article on X:

“Superstar Zeynep Irem Ozay presenting ASCO our real-world data showing lutetium has better survival outcomes than cabazitaxel in post-ARPI/docetaxel mCRPC patients.”

More posts featuring Nicolas Sayegh and ASCO 2025 on OncoDaily.